by Columbia University Irving Medical Center Credit: Pixabay/CC0 Public Domain A new study by Columbia University researchers suggests that cholesterol-lowering drugs called statins have the potential to reduce heart disease in people with obstructive sleep apnea, regardless of the use of CPAP machines during the night. The study is published in the journal Annals of the American Thoracic...
By Jessica Hagen February 15, 2023 10:36 am Photo: Westend61/Getty Images Belgian sleep-focused digital health startup Sunrise received FDA 510(k) clearance for its home sleep apnea test that’s placed on a user’s chin at night. The test utilizes a sensor that analyzes bio-signals from mandibular jaw movements, which can help calculate respiratory disturbance often found in sleep apnea patients....
Aaron B. Holley, MD January 10, 2023 The Agency for Healthcare Research and Quality (AHRQ) just released a new document on long-term health outcomes in patients with obstructive sleep apnea (OSA). AHRQ is a critically important organization that helps health systems, insurers, and providers develop policies for and approaches to care delivery at the individual and population levels. Its findings tend...
by Flinders University Credit: Pixabay/CC0 Public Domain A drug in development for obstructive sleep apnea (OSA) has shown promising results, after researchers from Flinders University tested the treatment in people for the first time. Designed to prevent the narrowing or collapse of the upper airways during sleep, a key factor in OSA, the treatment could...
by University of Queensland Urotensin II-saporin induces specific lesions of cholinergic neurons at mesopontine tegmentum. A Diagrams and photomicrographs of coronal sections of the brainstem, the right column being immunostained for ChAT-positive neurons within the laterodorsal tegmental nucleus (LDT) following unilateral direct injection of UII-saporin (UII-SAP) into the right mesopontine tegmentum (MPT). Scale bar =...
JOHNS HOPKINS MEDICINE In a new study with obese mice, Johns Hopkins Medicine researchers say they have added to evidence that specialized channel proteins are possible therapeutic targets for sleep apnea and similar abnormally slow breathing disorders in obese people. The protein, a cation channel known as TRPM7, is found in carotid bodies, tiny sensory...
by Flinders University Illustration of obstruction of ventilation. Credit: Habib M’henni / public domain Targeting a condition suffered by nearly a billion people worldwide, a new study from Flinders University has shown a drug previously used to treat depression can reduce obstructive sleep apnea (OSA) severity. While not yet identifying a cure, the authors say...
For patients with severe obstructive sleep apnea (OSA), withdrawal of positive airway pressure (PAP) is associated with changes in plasma Alzheimer disease biomarkers, according to a study published online June 13 in the American Journal of Respiratory and Critical Care Medicine. Korey Kam, Ph.D., from the Icahn School of Medicine at Mount Sinai in New York...
UNIVERSITY OF GOTHENBURG IMAGE: JAN HEDNER AND LUDGER GROTE, SAHLGRENSKA ACADEMY AT THE UNIVERSITY OF GOTHENBURG. CREDIT: PHOTO BY JOHAN WINGBORG A new University of Gothenburg study has paved the way for the first drug treatment for sleep apnea. Compared to before receiving the treatment, breathing pauses decreased with on average more than 20 per...
Folks with sleep apnea are typically prescribed a CPAP machine to help them get a good night’s sleep, but there’s an alternative to the clunky, noisy devices that is growing in popularity. Oral appliances similar to mouthguards—called mandibular advancement devices (MADs)—have been shown to work as well as CPAP in treating sleep apnea for many patients, experts say. MADs...
